This heterogeneous disease is categorized into five molecular subtypes: Luminal A, Luminal B, epidermal growth factor receptor 2–enriched (HER2+), basal-like, and normal-like breast cancers [6, 7]. This evidence concerns the gene ERBB2 and breast carcinoma.